Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 8-K | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Total revenues [+] | 158.2 | 130.3 | 80.1 | 45.5 | 31.9 | 23.4 | 13.3 | 11.6 |
| Products | | | | | | | 9.0 | |
| Healthcare | | | | | | | 4.3 | |
| Net interest income | | | | | -0.2 | | | |
| Revenue growth | 21.4% | 62.6% | 76.2% | 42.5% | 36.2% | 76.0% | 14.4% | 4.7% |
| Cost of goods sold | 114.7 | 93.7 | 17.4 | 8.8 | 6.0 | 4.8 | 3.5 | 4.9 |
| Gross profit | 43.5 | 36.6 | 62.7 | 36.7 | 25.9 | 18.6 | 9.8 | 6.7 |
| Gross margin | 27.5% | 28.1% | 78.3% | 80.6% | 81.1% | 79.4% | 73.6% | 57.6% |
| Selling, general and administrative [+] | 103.2 | 80.6 | 52.5 | 25.6 | 15.5 | 9.7 | 9.2 | 9.2 |
| Sales and marketing | 67.1 | 54.3 | 34.1 | 14.9 | 6.5 | | | |
| General and administrative [+] | 36.1 | 26.3 | 18.3 | 10.7 | 9.0 | | | |
| General and administrative expenses | 36.1 | 26.3 | 18.3 | 10.7 | 9.0 | | | |
| Other operating expenses | -82.7 | -66.4 | 0.1 | | | | | |
| EBITDA [+] | | | 11.7 | 11.8 | 10.8 | 9.2 | 1.1 | -2.1 |
| EBITDA growth | 2.6% | 90.4% | -0.8% | 9.5% | 17.2% | 758.6% | -152.3% | -59.2% |
| EBITDA margin | 14.5% | 17.2% | 14.7% | 26.0% | 33.9% | 39.4% | 8.1% | -17.7% |
| Depreciation | | | 1.6 | 0.8 | 0.4 | 0.3 | 0.4 | 0.4 |
| EBITA | 22.9 | 22.4 | 10.2 | 11.1 | 10.4 | 9.0 | 0.7 | -2.4 |
| EBITA margin | 14.5% | 17.2% | 12.7% | 24.3% | 32.5% | 38.3% | 5.1% | -20.8% |
| Amortization of intangibles | | | | | | 0.0 | 0.0 | 0.1 |
| EBIT [+] | 22.9 | 22.4 | 10.2 | 11.1 | 10.4 | 8.9 | 0.6 | -2.5 |
| EBIT growth | 2.6% | 119.9% | -8.1% | 6.7% | 15.9% | 1297.5% | -125.8% | -56.5% |
| EBIT margin | 14.5% | 17.2% | 12.7% | 24.3% | 32.5% | 38.2% | 4.8% | -21.3% |
| Non-recurring items [+] | | | -0.1 | | | | | |
| Unusual expense | | | -0.1 | | | | | |
| Interest expense | 0.4 | 0.1 | 0.0 | 0.0 | | 1.5 | 0.4 | |
| Interest expense | 0.4 | 0.1 | 0.0 | 0.0 | | 1.5 | 0.4 | |
| Other income (expense), net [+] | -0.3 | | -0.1 | 0.9 | -0.2 | | -0.2 | -0.5 |
| Other | 0.7 | 0.1 | | | | | -0.2 | 0.0 |
| Pre-tax income | 22.2 | 22.3 | 10.2 | 11.9 | 10.2 | 7.5 | 0.1 | -3.0 |
| Income taxes | 5.2 | 5.2 | 1.1 | 2.4 | 0.7 | 0.1 | 0.0 | -0.1 |
| Tax rate | 23.2% | 23.2% | 10.6% | 20.5% | 6.5% | 1.7% | 17.9% | 1.9% |
| Net income | 17.0 | 17.1 | 9.1 | 9.5 | 9.6 | 7.4 | 0.1 | -2.9 |
| Net margin | 10.8% | 13.1% | 11.3% | 20.9% | 29.9% | 31.4% | 0.5% | -25.2% |
| |
| Basic EPS [+] | $0.44 | $0.45 | $0.27 | $0.29 | $0.29 | $0.23 | $0.00 | ($0.09) |
| Growth | -0.7% | 66.6% | -8.4% | -0.4% | 28.3% | 10280.1% | -102.4% | -52.8% |
| Diluted EPS [+] | $0.44 | $0.44 | $0.26 | $0.28 | $0.28 | $0.22 | $0.00 | ($0.09) |
| Growth | -0.1% | 68.0% | -7.1% | -0.4% | 26.5% | 9954.9% | -102.4% | -52.8% |
| |
| Shares outstanding (basic) [+] | 38.5 | 38.3 | 33.9 | 32.4 | 32.5 | 32.2 | 31.3 | 31.3 |
| Growth | 0.4% | 13.1% | 4.4% | -0.2% | 1.1% | 2.8% | 0.0% | 0.2% |
| Shares outstanding (diluted) [+] | 39.1 | 39.2 | 34.9 | 34.0 | 34.0 | 33.2 | 31.3 | 31.3 |
| Growth | -0.2% | 12.2% | 2.9% | -0.2% | 2.6% | 6.2% | 0.0% | 0.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|